Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain
CompletedNot applicableNCT02935621
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The central aim of this proposed study is to test a multimodal, mindfulness-oriented intervention designed to disrupt the risk chain leading to prescription opioid dose escalation, opioid misuse and opioid addiction, which are mounting threats to active duty service members and Veterans with chronic pain conditions, who may develop disordered opioid use as a consequence of long-term opioid pharmacotherapy.
Study details
- Official title
- Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain Conditions and Opioid Related Problems
- Conditions
- Interventions
- Behavioral: Mindfulness-Oriented Recovery Enhancement (MORE)
- Behavioral: Support Group
- Sponsor
- University of Utah
- Collaborators
- United States Department of Defense
- Start date
- 2017-04-01
- Primary completion
- 2022-12-15
- Sex
- All
- Age range
- from 18 Years to 100 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * men/women ≥18 years of age * ability to understand and speak the English language * current chronic pain diagnosis (including but not limited to ICD-9 diagnoses 338.0, 338.2xx, 338. * current use of prescription opioids for \>3 consecutive months. Exclusion Criteria: * Mindfulness training experience (participation in MBSR/MBRP) * opioid withdrawal evidenced by score ≥13 on the Clinical Opiate Withdrawal Scale * current cancer diagnosis * having a psychiatric or medical condition that precludes the ability to provide informed consent or participation in outpatient treatment (e.g., psychosis, mania, acute intoxication
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02935621